Geode Capital Management, LLC Igm Biosciences, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 395,799 shares of IGMS stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
395,799
Previous 367,681 7.65%
Holding current value
$2.73 Million
Previous $2.53 Million 159.25%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$6.28 - $17.68 $176,581 - $497,126
28,118 Added 7.65%
395,799 $6.55 Million
Q2 2024

Aug 09, 2024
BUY
$6.51 - $11.47 $206,210 - $363,323
31,676 Added 9.43%
367,681 $2.53 Million
Q1 2024

May 13, 2024
BUY
$8.68 - $17.36 $81,149 - $162,298
9,349 Added 2.86%
336,005 $3.24 Million
Q4 2023

Feb 13, 2024
BUY
$3.94 - $8.79 $134,448 - $299,949
34,124 Added 11.67%
326,656 $2.71 Million
Q3 2023

Nov 13, 2023
BUY
$6.66 - $10.64 $480,285 - $767,303
72,115 Added 32.72%
292,532 $2.44 Million
Q2 2023

Aug 11, 2023
BUY
$8.86 - $14.0 $198,109 - $313,040
22,360 Added 11.29%
220,417 $2.03 Million
Q1 2023

May 15, 2023
BUY
$13.74 - $25.76 $59,178 - $110,948
4,307 Added 2.22%
198,057 $2.72 Million
Q4 2022

Feb 13, 2023
BUY
$15.45 - $26.02 $165,855 - $279,324
10,735 Added 5.87%
193,750 $3.3 Million
Q3 2022

Nov 14, 2022
SELL
$15.42 - $27.01 $211,176 - $369,901
-13,695 Reduced 6.96%
183,015 $4.16 Million
Q2 2022

Aug 12, 2022
SELL
$13.27 - $25.5 $233,180 - $448,086
-17,572 Reduced 8.2%
196,710 $3.55 Million
Q1 2022

May 13, 2022
BUY
$13.42 - $29.73 $927,335 - $2.05 Million
69,101 Added 47.6%
214,282 $5.73 Million
Q4 2021

Feb 11, 2022
SELL
$27.59 - $66.39 $226,734 - $545,593
-8,218 Reduced 5.36%
145,181 $4.26 Million
Q3 2021

Nov 12, 2021
BUY
$65.76 - $90.65 $551,726 - $760,553
8,390 Added 5.79%
153,399 $10.1 Million
Q2 2021

Aug 13, 2021
BUY
$57.98 - $96.6 $518,515 - $863,893
8,943 Added 6.57%
145,009 $12.1 Million
Q1 2021

May 12, 2021
BUY
$71.56 - $121.23 $1.24 Million - $2.1 Million
17,340 Added 14.61%
136,066 $10.4 Million
Q4 2020

Feb 12, 2021
SELL
$47.41 - $115.03 $70,735 - $171,624
-1,492 Reduced 1.24%
118,726 $10.5 Million
Q3 2020

Nov 13, 2020
SELL
$43.0 - $84.01 $1.75 Million - $3.42 Million
-40,685 Reduced 25.29%
120,218 $8.87 Million
Q2 2020

Aug 13, 2020
BUY
$51.3 - $75.21 $481,399 - $705,770
9,384 Added 6.19%
160,903 $11.7 Million
Q1 2020

May 14, 2020
BUY
$31.51 - $73.75 $912,687 - $2.14 Million
28,965 Added 23.63%
151,519 $8.51 Million
Q4 2019

Feb 13, 2020
BUY
$17.25 - $49.51 $2.11 Million - $6.07 Million
122,554 New
122,554 $4.68 Million

Others Institutions Holding IGMS

# of Institutions
81
Shares Held
20.7M
Call Options Held
68K
Put Options Held
52.2K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $200M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email